MDMA ("ecstasy") : a currently used drug in Spain
Prat, A.; Montero, M.; Reig, R.; Sanz, P.
Revista Clinica Espanola 188(2): 106-108
1991
ISSN/ISBN: 0014-2565 PMID: 1675014 Document Number: 374695
Document emailed within 1 workday
Related Documents
Szukaj, M. 1994: MDMA ("Ecstasy")--a dangerous drug or psychotherapeutic drug? Der Nervenarzt 65(11): 802-805Chishiro, T.; Matsubara, M.; Kiuchi, S. 2003: Two cases of "Ecstasy (MDMA)" poisoning Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi 16(4): 463-464
Dowling, G.P.; McDonough, E.T.; Bost, R.O. 1987: 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA JAMA 257(12): 1615-1617
Ezoubi, S.; Kahal, H.; Waring, W.S. 2016: Pneumomediastinum as a complication of MDMA (3,4-methylenedioxymetamfetamine, Ecstasy) ingestion Acute Medicine 15(3): 152-156
O'Connor, A.; Cluroe, A.; Couch, R.; Galler, L.; Lawrence, J.; Synek, B. 1999: Death from hyponatraemia-induced cerebral oedema associated with MDMA ("Ecstasy") use New Zealand Medical Journal 112(1091): 255-256
Rukskul, P. 2005: Ecstasy (MDMA) ingestion related with severe hyponatremia in patients with mild head injury Journal of the Medical Association of Thailand 88(1): 41-44
De Visme, P.G. 1998: Neurotoxicity of the drug Ecstasy. Functional consequences of serotonergic hypoactivity Ugeskrift for Laeger 160(42): 6088-6091
Wilkins, C.; Bhatta, K.; Pledger, M.; Casswell, S. 2003: Ecstasy use in New Zealand: findings from the 1998 and 2001 National Drug Surveys New Zealand Medical Journal 116(1171): U383
Verdejo-García, A.; Pérez-García, M.; Sánchez-Barrera, M.; Rodriguez-Fernández, A.; Gómez-Río, M. 2007: Neuroimaging and drug addiction: neuroanatomical correlates of cocaine, opiates, cannabis and ecstasy abuse Revista de Neurologia 44(7): 432-439
Navarro, F.A. 1995: Drug nomenclature (II). International common names in Spain Medicina Clinica 105(10): 382-388
Darbà, J.; Ascanio, M. 2019: Therapy for Gastroenteropancreatic Neuroendocrine Tumors: drug evaluation reports review in Spain Neuro Endocrinology Letters 39(8): 537-543
Pineda, J.A.; Aguado, I.; Rivero, A.; Vergara, A.; Hernández-Quero, J.; Luque, F.; Pino, R.; Abad, M.A.; Santos, J.; Cruz, E. 1992: HIV-1 infection among non-intravenous drug user female prostitutes in Spain. no evidence of evolution to pattern Ii Aids 6(11): 1365-1369
Lardelli, P.; de la Fuente, L.; Alonso, J.M.; López, R.; Bravo, M.J.; Delgado-Rodríguez, M. 1993: Geographical variations in the prevalence of HIV infection among drug users receiving ambulatory treatment in Spain International Journal of Epidemiology 22(2): 306-314
Bruguera, M.; Buti, M.; Diago, M.; García Bengoechea, M.; Jara, P.; Pedreira, J.A.; Ruiz Extremera, A. 1997: Indications and prescription of hepatitis A vaccine in Spain. Report of the Spain Association for the Study of the Liver Gastroenterologia y Hepatologia 20(9): 467-473
Shen, M.; Yan, W.; Shen, B.; Xiang, P.; Huang, Z.; Liu, W.; Bo, J. 1998: Analysis of MDMA and its metabolites in urine by GC and GC/MS Fa Yi Xue Za Zhi 14(1): 10
Winstock, A.R. 1991: Chronic paranoid psychosis after misuse of MDMA Bmj 302(6785): 1150-1151
Miró, Òs.; Yates, C.; Dines, A.M.; Wood, D.M.; Dargan, P.I.; Galán, I.; Jerez, A.; Puiguriguer, J.; Waring, W.S.; Moughty, A.; O'Connor, N.; Heyerdahl, F.; Hovda, K.E.; Vallersnes, O.M.; Paasma, R.; Põld, K.; Jürgens, G.; Megarbane, B.; Anand, J.S.; Liakoni, E.; Liechti, M.; Eyer, F.; Zacharov, S.; Caganova, B.; Giraudon, I.; Galicia, M. 2018: Emergencies related to recreational drug abuse in Spain compared to emergencies attended in 3 European areas Emergencias: Revista de la Sociedad Espanola de Medicina de Emergencias 30(6): 385-394
Ramos, J.M.; Fitzgerald, R.L.; Poklis, A. 1988: MDMA and MDA cross reactivity observed with Abbott TDx amphetamine/methamphetamine reagents Clinical Chemistry 34(5): 991
Trkulja, V.; Lacković, Z. 1997: Ecstasy Lijecnicki Vjesnik 119(5-6): 158-166
Gouzoulis-Mayfrank, E.; Hermle, L. 1994: The dangers of "ecstasy" Der Nervenarzt 65(9): 648-650